Pathologic complete response to cisplatin with dose-dense paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: Preliminary results of a multicenter phase II study with additional mutation analysis of adeno/adenosquamous carcinoma.
Maki Tanioka
No relevant relationships to disclose
Satoshi Yamaguchi
No relevant relationships to disclose
Shinya Sato
No relevant relationships to disclose
Shoji Nagao
No relevant relationships to disclose
Kazuhiro Takehara
No relevant relationships to disclose
Masato Nishimura
No relevant relationships to disclose
Tamotsu Sudo
No relevant relationships to disclose
Satoshi Morita
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Hironobu Minami
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Shunichi Negoro
No relevant relationships to disclose
Muneaki Shimada
No relevant relationships to disclose
Junzo Kigawa
No relevant relationships to disclose
Kiyoshi Fujiwara
No relevant relationships to disclose